News and Events

Benefits of deep learning for dermatologist-level detection of suspicious pigmented skin lesions from wide-field images

25 February 2021

According to to this recent study, deep learning for dermatologist-level detection of suspicious pigmented skin lesions from wide-field images could allow for rapid and accurate assessments of pigmented lesion suspiciousness within a primary care visit. It could also enable improved patient triaging, utilization of resources, and earlier treatment of melanoma.

Metformin is associated with decreased risk of basal cell carcinoma

25 February 2021

According to this recent study, metformin is associated with decreased risk of basal cell carcinoma (BCC)development, even at low doses. Metformin might have potential as a chemoprotective agent for patients at high risk of BCC, although this will need confirmation in future studies.

Focus on adjuvant immunotherapy for melanoma

25 February 2021

Immunotherapy in the form of checkpoint inhibitors ipilimumab, nivolumab, and pembrolizumab have been shown to improve recurrence-free survival for node-positive melanoma in the adjuvant setting and are the focus of this review.

Identification of preoperative peripheral inflammatory markers as indicators for poor prognosis in melanoma patients with brain metastases undergoing neurosurgical treatment

17 February 2021

This recent study identified several preoperative peripheral inflammatory markers as indicators for poor prognosis in melanoma patients with brain metastases undergoing neurosurgical treatment. Elevated initial C-reactive proteinvalues, higher neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio, and lower lymphocyte-to-monocyte ratio were associated with reduced overall survival.